To set the grounds for assessing CETP inhibitors for potential drug repurposing in Alzheimer’s disease, we showed here that evacetrapib reaches brain tissue fast after intravenous injection in hCETPtg mice. This evidence concerns the gene CETP and early-onset autosomal dominant Alzheimer disease.